Variability in delivery of care and echocardiogram surveillance of Kawasaki disease

Congenital Heart Disease

Volumn 7, Issue 4, 2012, Pages 336-343

  Lowry, Adam W ^a   Knudson, Jarrod D ^a   Myones, Barry L ^a   Moodie, Douglas S ^a   Han, Yong S ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Coronary Artery Aneurysm; Disease Screening and Prevention; Kawasaki Disease; Quality Improvement

Indexed keywords

ARTICLE; CORONARY ARTERY; DISEASE SURVEILLANCE; ECHOCARDIOGRAPHY; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH SURVEY; HOSPITAL DISCHARGE; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

CHILD; CHILD, PRESCHOOL; GUIDELINE ADHERENCE; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES;

EID: 84864317684     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2012.00670.x     Document Type: Article

References (26)

1. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr. 1991;119:279-282.
2. Newburger JW, Takahashi M, Gerber MA, etal. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747-2771.
3. Fukazawa R. Long-term prognosis of Kawasaki disease: increased cardiovascular risk? Curr Opin Pediatr. 2010;22:587-592.
4. Gupta-Malhotra M, Gruber D, Abraham SS, etal. Atherosclerosis in survivors of Kawasaki disease. J Pediatr. 2009;155:572-577.
5. Mitani Y, Okuda Y, Shimpo H, etal. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation. 1997;96:454-461.
6. Senzaki H, Chen CH, Ishido H, etal. Arterial hemodynamics in patients after Kawasaki disease. Circulation. 2005;111:2119-2125.
7. Suzuki A, Miyagawa-Tomita S, Komatsu K, etal. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation. 2000;101:2935-2941.
8. Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol. 2001;22:138-142.
9. Newburger JW, Takahashi M, Beiser AS, etal. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639.
10. Fimbres AM, Shulman ST. Kawasaki disease. Pediatr Rev. 2008;29:308-315; quiz 15-16.
11. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998;133:254-258.
12. McCrindle BW, Li JS, Minich LL, etal. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116:174-179.
13. McMorrow Tuohy AM, Tani LY, Cetta F, etal. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? Am J Cardiol. 2001;88:328-330.
14. Scott JS, Ettedgui JA, Neches WH. Cost-effective use of echocardiography in children with Kawasaki disease. Pediatrics. 1999;104:e57.
15. Dajani AS, Taubert KA, Takahashi M, etal. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 1994;89:916-922.
16. McDonald A, Scranton M, Gillespie R, Mahajan V, Edwards GA. Voiding cystourethrograms and urinary tract infections: how long to wait? Pediatrics. 2000;105:E50.
17. Madsen NL, Drezner JA, Salerno JC. Sudden cardiac death screening in the athlete: a state-wide evaluation of the primary care provider. In: American Academy of Pediatrics 2011 National Conference and Exhibition. Boston, MA; 2011.
18. Sluysmans T, Colan SD. Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol. 2005;99:445-457.
19. Baer AZ, Rubin LG, Shapiro CA, etal. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Arch Pediatr Adolesc Med. 2006;160:686-690.
20. Newburger JW, Takahashi M, Burns JC, etal. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341-347.
21. Barron KS, Murphy DJ Jr, Silverman ED, etal. Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin. J Pediatr. 1990;117:638-644.
22. Crystal MA, Manlhiot C, Yeung RS, Smallhorn JF, McCrindle BW. Coronary artery dilation after Kawasaki disease for children within the normal range. Int J Cardiol. 2009;136:27-32.
23. Kato H, Sugimura T, Akagi T, etal. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379-1385.
24. Senzaki H. Long-term outcome of Kawasaki disease. Circulation. 2008;118:2763-2772.
25. Gersony WM. The adult after kawasaki disease the risks for late coronary events. J Am Coll Cardiol. 2009;54:1921-1923.
26. Gordon JB, Kahn AM, Burns JC. When children with kawasaki disease grow up myocardial and vascular complications in adulthood. J Am Coll Cardiol. 2009;54:1911-1920.